Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma. (Q39127112)
Jump to navigation
Jump to search
scientific article published on September 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma. |
scientific article published on September 2003 |
Statements
Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma (English)
Pontus K E Börjesson
Ernst J Postema
Jan C Roos
David R Colnot
Henri A M Marres
Mathijs H van Schie
Gerd Stehle
Gordon B Snow
Guus A M S van Dongen
1 September 2003